Musk calls Neuralink's Blindsight ready as public trial evidence remains absent

Neuralink is awaiting regulatory approval for its second product, which aims to restore sight in blind patients, according to Tom's Hardware. RuntimeWire reports that the company still lists future trials, while rival vision implants from Cortigent and PRIMA have published participant results.

Covered by 2 publishers within an hour of the first report.

• Tom's Hardware: Elon Musk says Neuralink's 'BlindSight' is ready to cure blindness

Reporting2

TH Tom's Hardware Elon Musk says Neuralink's 'BlindSight' is ready to cure blindness · Jowi Morales 8:30 AM

RTW RuntimeWire Neuralink's Blindsight has no public trial record while rival vision implants publish patient data · RuntimeWire Staff 8:45 AM

Related

TNW The X ticker is free as Musk weighs a SpaceX-Tesla merger October 29

BL Musk says SpaceX and Tesla boards are considering a merger October 26

G The staggering $446m Elon Musk has spent on the US midterms – visualized October 30

GZ Musk Claims Ukraine Violated Starlink Terms of Service October 27

Topics Elon Musk